Expanded phenotype and cancer risk in patients with Beckwith–Wiedemann spectrum caused by CDKN1C variants
American Journal of Medical Genetics Part A · 2024-10 · 194 (10)
DOI: 10.1002/ajmg.a.63777 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024-06. Verfasst von Andrew M George und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Beckwith-Wiedemann Syndrome, Cyclin-Dependent Kinase Inhibitor p57, Phenotype, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Beckwith–Wiedemann spectrum (BWSp) is caused by genetic and epigenetic alterations on chromosome 11 that regulate cell growth and division. Considering the diverse phenotypic landscape in BWSp, the characterization of the CDKN1C molecular subtype remains relatively limited. Here, we investigate the role of CDKN1C in the broader BWSp phenotype. Notably, patients with CDKN1C variants appear to exhibit a different tumor risk than other BWSp molecular subtypes. We performed a comprehensive literature review using the search term “ CDKN1C Beckwith” to identify 113 cases of patients with molecularly confirmed CDKN1C‐ BWSp. We then assessed the genotype and phenotype in a novel cohort of patients with CDKN1C ‐BWSp enrolled in the BWS Research Registry. Cardinal and suggestive features were evaluated for all patients reported, and tumor risk was established based on available reports. The most common phenotypes included macroglossia, omphalocele, and ear creases/pits. Tumor types reported from the literature included neuroblastoma, acute lymphocytic leukemia, superficial spreading melanoma, and intratubular germ cell neoplasia. Overall, this study identifies unique features associated with CDKN1C variants in BWSp, enabling more accurate clinical management. The absence of Wilms tumor and hepatoblastoma suggests that screening for these tumors may not be necessary, while the neuroblastoma risk warrants appropriate screening recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Andrew M George, Aravind Viswanathan, Lyle G Best, Arupa Ganguly, Jennifer M Kalish
Zitieren
APA
George, A. M., Viswanathan, A., Best, L. G., Monahan, C., Limmina, M., Ganguly, A., & Kalish, J. M. (2024). Expanded phenotype and cancer risk in patients with Beckwith–Wiedemann spectrum caused by CDKN1C variants. American Journal of Medical Genetics Part A, 194(10). https://doi.org/10.1002/ajmg.a.63777
Vancouver
George AM, Viswanathan A, Best LG, Monahan C, Limmina M, Ganguly A, et al. Expanded phenotype and cancer risk in patients with Beckwith–Wiedemann spectrum caused by CDKN1C variants. American Journal of Medical Genetics Part A. 2024;194(10). doi:10.1002/ajmg.a.63777
BibTeX
@article{George2024,
author = {George, Andrew M and Viswanathan, Aravind and Best, Lyle G and Monahan, Caitlin and Limmina, Maria and Ganguly, Arupa and Kalish, Jennifer M},
title = {Expanded phenotype and cancer risk in patients with Beckwith–Wiedemann spectrum caused by CDKN1C variants},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
volume = {194},
number = {10},
doi = {10.1002/ajmg.a.63777}
}
EUVIMED